| - | Discovery of lipid biomarker candidates for myocardial infarction and angina pectoris using lipidomic approach | Choi Jong min; Lee Hwa Jeong; Jung, Byung Hwa |
| - | Establishment of Plasma Lipidomic Platform using UPLC-QTOF | Choi Jong min; Hwa Jeong Lee; Jung, Byung Hwa |
| - | Global metabolomic analysis for finding biomarker candidates from acute myocardial infarction disease | Choi Jong min; Lee Hwa Jeong; Jung, Byung Hwa |
| - | Lipid biomarker candidates from rosuvastatin-treated human plasma using lipidomic platform | Choi Jong min; Lee Hwa Jung; Jung, Byung Hwa |
| - | Lipidomic approach to study metabolic changes in oral administration of rosuvastatin in both healthy human and hypercholesterolemic patients | Choi Jong min; Lee Hwa Jeong; Jung, Byung Hwa |
| - | Lipidomic profiling after statin drug treatment | Jung, Byung Hwa; Choi Jong min; Joo-Youn Cho |
| - | Metabolomic approach for finding biomarker candidates of statin-induced myopathy | Choi Jong min; Chung, Bong Chul; Hwa Jeong Lee; Jung, Byung Hwa |
| - | Quantitative analysis of tryptophan and its metabolites from gastric juice using LC-MS/MS system | Choi Jong min; Hwa Jeong Lee; Jung, Byung Hwa |
| - | Quantitative Analysis of Tryptophan and Its Metabolites from Plasma in Gastric Cancer Patients Using LC-MS/MS | Choi Jong min; Hwa Jeong Lee; Jung, Byung Hwa |
| - | Simultaneous quantitative analysis of tryptophan and its metabolites in plasma using LC-MS/MS | Choi Jong min; Lee Hwa Jeong; Jung, Byung Hwa |
| - | The phosphatidylcholine profile for the effect of rosuvastatin in human plasma using a lipidomic approach and the retention time index | Jung, Byung Hwa; Choi Jong min |
